Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven T Szabo

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2002
Effects of serotonin (5-hydroxytryptamine, 5-HT) reuptake inhibition plus 5-HT(2A) receptor antagonism on the firing activity of norepinephrine neuronsSteven T Szabo, Pierre Blier
Psychiatry Research|April 10, 2018
Maintenance ECT in schizophrenia: A systematic reviewHeather Burrell Ward, Steven T Szabo, Gopalkumar Rakesh
The International Journal of Neuropsychopharmacology|May 10, 2001
Progressive attenuation of the firing activity of locus coeruleus noradrenergic neurons by sustained administration of selective serotonin reuptake inhibitorsSteven T. Szabo, Claude de Montigny, Pierre Blier
International Journal of Clinical Pharmacology and Therapeutics|September 5, 2018
Effect of γ-hydroxybutyrate (Xyrem) on locus coeruleus activity as measured by pupillometry in a patient with narcolepsySteven T Szabo, Kelly Kandra, Andrew D Krystal
Human Psychopharmacology|October 31, 2002
Enhancement of serotoninergic function - a sometimes insufficient cause of antidepressant actionPierre Blier, Nasser Haddjeri, Steven T Szabo, et al.
CNS Spectrums|July 25, 2019
Efficacy and safety of ketamine in the management of anxiety and anxiety spectrum disorders: a review of the literatureMichael D Banov, Jonathan R Young, Tyler Dunn, et al.
Contemporary Clinical Trials|August 4, 2024
A clinical trial inclusion criteria to enrich for patients presenting with canonical symptom structure in bipolar depressionSeth C Hopkins, Sasagu Tomioka, Steven T Szabo, et al.
Therapeutic Advances in Chronic Disease|August 18, 2017
Strategies for dementia prevention: latest evidence and implicationsGopalkumar Rakesh, Steven T Szabo, George S Alexopoulos, et al.
Behavioural Brain Research|January 14, 2014
Time-dependent changes in nicotine behavioral responsivity during early withdrawal from chronic cocaine administration and attenuation of cocaine sensitization by mecamylamineSteven T Szabo, J C Fowler, Brett Froeliger, et al.
The International Journal of Neuropsychopharmacology|May 25, 2004
Focus on CaMKII: a molecular switch in the pathophysiology and treatment of mood and anxiety disordersJing Du, Steven T Szabo, Neil A Gray, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2002
Effects of serotonin (5-hydroxytryptamine, 5-HT) reuptake inhibition plus 5-HT(2A) receptor antagonism on the firing activity of norepinephrine neuronsSteven T Szabo, Pierre Blier
Psychiatry Research|April 10, 2018
Maintenance ECT in schizophrenia: A systematic reviewHeather Burrell Ward, Steven T Szabo, Gopalkumar Rakesh
The International Journal of Neuropsychopharmacology|May 10, 2001
Progressive attenuation of the firing activity of locus coeruleus noradrenergic neurons by sustained administration of selective serotonin reuptake inhibitorsSteven T. Szabo, Claude de Montigny, Pierre Blier
International Journal of Clinical Pharmacology and Therapeutics|September 5, 2018
Effect of γ-hydroxybutyrate (Xyrem) on locus coeruleus activity as measured by pupillometry in a patient with narcolepsySteven T Szabo, Kelly Kandra, Andrew D Krystal
Human Psychopharmacology|October 31, 2002
Enhancement of serotoninergic function - a sometimes insufficient cause of antidepressant actionPierre Blier, Nasser Haddjeri, Steven T Szabo, et al.
CNS Spectrums|July 25, 2019
Efficacy and safety of ketamine in the management of anxiety and anxiety spectrum disorders: a review of the literatureMichael D Banov, Jonathan R Young, Tyler Dunn, et al.
Contemporary Clinical Trials|August 4, 2024
A clinical trial inclusion criteria to enrich for patients presenting with canonical symptom structure in bipolar depressionSeth C Hopkins, Sasagu Tomioka, Steven T Szabo, et al.
Therapeutic Advances in Chronic Disease|August 18, 2017
Strategies for dementia prevention: latest evidence and implicationsGopalkumar Rakesh, Steven T Szabo, George S Alexopoulos, et al.
Behavioural Brain Research|January 14, 2014
Time-dependent changes in nicotine behavioral responsivity during early withdrawal from chronic cocaine administration and attenuation of cocaine sensitization by mecamylamineSteven T Szabo, J C Fowler, Brett Froeliger, et al.
The International Journal of Neuropsychopharmacology|May 25, 2004
Focus on CaMKII: a molecular switch in the pathophysiology and treatment of mood and anxiety disordersJing Du, Steven T Szabo, Neil A Gray, et al.
Pageof 6